H Bui1, I Zablotska-Manos2, M Hammoud2, F Jin2, T Lea3, A Bourne4, J Iversen2, N Bath5, J Grierson6, L Degenhardt7, G Prestage2, L Maher8. 1. The Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, NSW, Australia; Center for Research and Training on HIV/AIDS (CREATA), Hanoi Medical University, Hanoi, Vietnam. 2. The Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, NSW, Australia. 3. Centre for Social Research in Health, UNSW Sydney, Sydney, NSW, Australia; German Institute for Addiction and Prevention Research (DISuP), Catholic University of Applied Sciences, North Rhine-Westphalia, Germany. 4. Australian Research Centre in Sex, Health & Society, La Trobe University, Melbourne, VIC, Australia. 5. ACON, Sydney, NSW, Australia. 6. Faculty of Health, Social Care and Education, Anglia Ruskin University, Cambridge, United Kingdom. 7. National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, NSW, Australia. 8. The Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, NSW, Australia. Electronic address: Lmaher@kirby.unsw.edu.au.
Abstract
BACKGROUND: While illicit drug use is prevalent among gay and bisexual men (GBM) in Australia, little is known about the factors associated with injecting drug use among GBM. METHODS: The Following Lives Undergoing Change (FLUX) study is a national, online prospective observational cohort investigating drug use among Australian GBM. Eligible participants were men living in Australia who were aged 16.5 years or older, identified as gay or bisexual or had sex with at least one man in the last year. We examined baseline data for associations between socio-demographic and behavioural characteristics and recent (last six months) injecting using log-binomial regression. RESULTS: Of 1995 eligible respondents, 206 (10.3%) reported ever injecting drugs and 93 (4.7%) had injected recently, most commonly crystal (91.4%) and speed (9.7%). Among recent injectors, only 16 (17.2%) reported injecting at least weekly; eight (8.6%) reported recent receptive syringe sharing. Self-reported HIV and HCV prevalence was higher among recent injectors than among other participants (HIV: 46.2% vs 5.0%, p < .001; HCV: 16.1% vs. 1.2%, p < .001). Recent injecting was associated with lifetime use of more drug classes (adjusted prevalence ratio (APR) = 1.31, 95% Confidence Interval (95%CI) 1.21-1.41), longer time since initiating party drug use (APR = 1.02, 95%CI 1.01-1.04), greater numbers of sex partners (2-10 sex partners: APR = 3.44, 95%CI 1.45-8.20; >10 sex partners: APR = 3.21, 95%CI 1.30-7.92), group sex (APR = 1.42, 95%CI 1.05-1.91) and condomless anal intercourse with casual partners (APR = 1.81, 95%CI 1.34-2.43) in the last six months. CONCLUSIONS: Observed associations between injecting and sexual risk reflect a strong relationship between these practices among GBM. The intersectionality between injecting drug use and sex partying indicates a need to integrate harm reduction interventions for GBM who inject drugs into sexual health services and targeted sexual health interventions into Needle and Syringe Programs.
BACKGROUND: While illicit drug use is prevalent among gay and bisexual men (GBM) in Australia, little is known about the factors associated with injecting drug use among GBM. METHODS: The Following Lives Undergoing Change (FLUX) study is a national, online prospective observational cohort investigating drug use among Australian GBM. Eligible participants were men living in Australia who were aged 16.5 years or older, identified as gay or bisexual or had sex with at least one man in the last year. We examined baseline data for associations between socio-demographic and behavioural characteristics and recent (last six months) injecting using log-binomial regression. RESULTS: Of 1995 eligible respondents, 206 (10.3%) reported ever injecting drugs and 93 (4.7%) had injected recently, most commonly crystal (91.4%) and speed (9.7%). Among recent injectors, only 16 (17.2%) reported injecting at least weekly; eight (8.6%) reported recent receptive syringe sharing. Self-reported HIV and HCV prevalence was higher among recent injectors than among other participants (HIV: 46.2% vs 5.0%, p < .001; HCV: 16.1% vs. 1.2%, p < .001). Recent injecting was associated with lifetime use of more drug classes (adjusted prevalence ratio (APR) = 1.31, 95% Confidence Interval (95%CI) 1.21-1.41), longer time since initiating party drug use (APR = 1.02, 95%CI 1.01-1.04), greater numbers of sex partners (2-10 sex partners: APR = 3.44, 95%CI 1.45-8.20; >10 sex partners: APR = 3.21, 95%CI 1.30-7.92), group sex (APR = 1.42, 95%CI 1.05-1.91) and condomless anal intercourse with casual partners (APR = 1.81, 95%CI 1.34-2.43) in the last six months. CONCLUSIONS: Observed associations between injecting and sexual risk reflect a strong relationship between these practices among GBM. The intersectionality between injecting drug use and sex partying indicates a need to integrate harm reduction interventions for GBM who inject drugs into sexual health services and targeted sexual health interventions into Needle and Syringe Programs.
Authors: Liza Coyer; Anders Boyd; Udi Davidovich; Ward P H van Bilsen; Maria Prins; Amy Matser Journal: Addiction Date: 2021-09-22 Impact factor: 7.256
Authors: Sofia R Bartlett; Tanya L Applegate; Brendan P Jacka; Marianne Martinello; Francois Mj Lamoury; Mark Danta; Daniel Bradshaw; David Shaw; Andrew R Lloyd; Margaret Hellard; Gregory J Dore; Gail V Matthews; Jason Grebely Journal: J Int AIDS Soc Date: 2019-02 Impact factor: 5.396
Authors: Helen Dolengevich-Segal; Alicia Gonzalez-Baeza; Jorge Valencia; Eulalia Valencia-Ortega; Alfonso Cabello; Maria Jesus Tellez-Molina; Maria Jesus Perez-Elias; Regino Serrano; Leire Perez-Latorre; Luz Martin-Carbonero; Sari Arponen; Jose Sanz-Moreno; Sara De la Fuente; Otilia Bisbal; Ignacio Santos; Jose Luis Casado; Jesus Troya; Miguel Cervero-Jimenez; Sara Nistal; Guillermo Cuevas; Javier Correas-Lauffer; Marta Torrens; Pablo Ryan Journal: PLoS One Date: 2019-12-04 Impact factor: 3.240
Authors: Oskar Ayerdi Aguirrebengoa; Mar Vera Garcia; Teresa Puerta López; Petunia Clavo Escribano; Juan Ballesteros Martín; Clara Lejarrag Cañas; Enrique Fuentes Ferrer; Montserrat Raposo Utrilla; Vicente Estrada Perez; Jorge Del Romero Guerrero; Carmen Rodríguez Martín Journal: Euro Surveill Date: 2021-11
Authors: Nadia Hanum; Valentina Cambiano; Janey Sewell; Alison J Rodger; Nneka Nwokolo; David Asboe; Richard Gilson; Amanda Clarke; Ada R Miltz; Simon Collins; Valerie Delpech; Sara Croxford; Andrew N Phillips; Fiona C Lampe Journal: PLoS Med Date: 2021-06-18 Impact factor: 11.069